Body Dysmorphic Disorder

Clinical picture

• Preoccupation most often targets skin, hair, and nose, though any body area may be involved; muscle dysmorphia predominates among men.
• Repetitive behaviors include mirror checking, camouflaging with clothing or makeup, skin picking, excessive grooming, and comparing with others.
• Patients present to dermatology and cosmetic surgery rather than psychiatry; procedures rarely satisfy and often shift or worsen the preoccupation.
• Insight is poor or absent in roughly a third of patients, yet delusional conviction does not change treatment, which remains an SSRI plus CBT.
• Social avoidance, school or work dropout, and housebound periods are common; many spend three to eight hours daily on appearance concerns.
• Patients describe themselves as ugly or deformed rather than fat, which is the key phenomenologic split from an eating disorder.

Criteria snapshot

• Preoccupation with one or more perceived appearance flaws that are unobservable or appear only slight to others, sustained rather than fleeting.
• At least one repetitive behavior or mental act, such as mirror checking, grooming, reassurance seeking, or comparing appearance with others.
• The preoccupation causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.
• If the concern centers on body fat or weight in someone meeting eating disorder criteria, the eating disorder diagnosis takes precedence.
• Specifiers cover muscle dysmorphia and insight level, ranging from good or fair through poor to absent and delusional conviction.

Neurobiology

• Visual processing is abnormally detail-oriented, with local rather than global configural analysis in occipitotemporal and parietal networks.
• Orbitofrontal-striatal circuitry overlaps substantially with OCD, which supports classification within the obsessive-compulsive and related disorders.
• Serotonergic dysfunction is inferred from selective SSRI response; noradrenergic and non-serotonergic antidepressants are comparatively ineffective.
• Family studies show elevated rates of OCD among first-degree relatives, and heritability estimates for BDD approach 40%.
• Functional imaging demonstrates amygdala hyperactivity and aberrant frontostriatal engagement when patients view images of their own face.
• Elevated rates of childhood teasing, abuse, and neglect suggest stress-related shaping of appearance-based threat detection systems.

Psychology

• Selective attention to appearance detail, prolonged mirror gazing that magnifies perceived flaws, and appearance-contingent self-worth maintain the disorder.
• Core cognitive distortions center on being judged, rejected, or deemed unlovable specifically because of the perceived physical defect.
• Camouflage, avoidance, and reassurance seeking function as safety behaviors that prevent disconfirmation of the feared social outcome.
• Perfectionism and heightened aesthetic sensitivity are elevated, with unusually strict internal standards for symmetry and proportion.
• Early appearance-focused teasing, bullying, and family emphasis on looks are common developmental precursors to onset in adolescence.

Differential & comorbidity

• Separate from normal appearance concern by the time consumed, the distress generated, and the functional impairment that follows.
• Anorexia nervosa involves weight and shape with restriction; gender dysphoria involves sex characteristics and identity, not a perceived defect.
• Comorbid major depression occurs in roughly 75% of patients, social anxiety disorder in about 35%, and substance use disorders in about 30%.
• Lifetime suicidal ideation approaches 80% and attempts reach 24-28%, exceeding rates in OCD and major depression, so screen at every contact.
• Skin picking driven by appearance concerns is coded as BDD rather than as excoriation disorder, and the same rule applies to hair removal.

Pharmacologic treatment

• High-dose SSRIs are first-line: fluoxetine 40-80 mg/day, escitalopram 20-30 mg/day, or sertraline 150-200 mg/day as tolerated.
• Allow 12-16 weeks at an optimized dose; response is slower than in depression, with roughly 53-70% of patients responding.
• Clomipramine 150-250 mg/day outperformed desipramine in controlled comparison, confirming serotonergic specificity; monitor ECG and anticholinergic load.
• Augment partial response with buspirone 30-60 mg/day or a low-dose antipsychotic; antipsychotic monotherapy fails even in delusional presentations.
• Continue medication at least one year after response, since relapse rates are high with premature discontinuation or dose reduction.

Psychotherapy

• CBT tailored to BDD across 18-24 weekly sessions is first-line, built on mirror retraining, exposure, and ritual prevention.
• Perceptual retraining teaches holistic rather than detail-focused self-viewing and directly reduces mirror-checking time and distress.
• Cognitive restructuring targets appearance-contingent self-worth and mind reading about how others evaluate the perceived defect.
• Habit reversal training is layered in for BDD-related skin picking and hair pulling, which otherwise persist after core CBT ends.
• Motivational interviewing improves engagement in poor-insight patients who are seeking cosmetic rather than psychiatric intervention.

Adjunct options

• Administer the BDD-YBOCS at baseline and every 4-6 weeks; a 30% score reduction is the conventional threshold for response.
• Explicitly discourage cosmetic, dermatologic, and surgical procedures, since satisfaction is rare and preoccupation typically migrates to a new area.
• Coordinate with dermatology and plastic surgery colleagues so that screened patients route back to mental health rather than to a procedure.
• Safety planning, lethal means restriction, and escalation to a higher level of care are warranted given the markedly elevated suicide risk.
• Residential and intensive outpatient OCD-spectrum programs help housebound patients and those with severe avoidance or delusional insight.

Clinical pearls

• Patients say ugly, not fat; that single word separates BDD from an eating disorder.
• Delusional BDD is a severity specifier, not psychosis: treat with SSRI plus CBT.
• Ask about cosmetic procedures; repeated dissatisfaction is a strong diagnostic clue.